Spot Stopper Acne Spot Treatment

Description

HONEST® SPOT STOPPER ACNE SPOT TREATMENT is formulated with wintergreen-derived salicylic acid and witch hazel. This product is available in a 0.5 fl. oz. (15 mL) dosage form. It is distributed by The Honest Company, Inc., located in Los Angeles, CA 90094, and is made in the USA from both US and imported materials. For more information, visit HONEST.COM or contact customer service at 888-862-8818.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The recommended application involves covering the entire affected area with a thin layer.

Initially, the product should be applied once daily. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily.

In cases where bothersome dryness or peeling occurs, it is advisable to reduce the application frequency to once daily or every other day to mitigate these effects.

Contraindications

Use is contraindicated in the following situations:

• The product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is required.

• Contact with eyes must be avoided. If contact occurs, it is essential to rinse the eyes thoroughly with water.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to adhere strictly to this guideline to prevent unintended systemic exposure.

Skin irritation and dryness may be exacerbated when using this product concurrently with other topical acne medications. It is recommended that patients use only one topical acne treatment at a time to minimize the risk of irritation. Should irritation occur, patients should discontinue use of all topical acne medications and consult a healthcare provider.

Healthcare professionals should instruct patients to avoid contact with the eyes. In the event of accidental contact, patients should rinse the affected area thoroughly with water to mitigate potential irritation.

In cases of ingestion, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay. Prompt action is crucial to ensure patient safety.

No specific laboratory tests are recommended for monitoring the use of this product. However, healthcare providers should remain vigilant for any signs of adverse reactions in patients using this medication.

Side Effects

Patients using this product should be aware that it is for external use only. The most common adverse reactions reported include skin irritation and dryness, particularly when used concurrently with other topical acne medications. To minimize the risk of these reactions, it is advised that patients use only one topical acne medication at a time.

Additionally, care should be taken to avoid contact with the eyes. In the event of accidental contact, patients should rinse the affected area thoroughly with water to alleviate any potential discomfort.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Spot Stopper Acne Spot Treatment (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of Spot Stopper Acne Spot Treatment in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this treatment to geriatric patients, as the absence of data necessitates careful monitoring and assessment of the patient's response to therapy.

Pregnancy

Pregnant patients should be aware that the safety of this medication during pregnancy has not been specifically established. There are no available data regarding the potential risks or fetal outcomes associated with the use of this medication in pregnant individuals. Healthcare professionals are advised to consider the lack of information when prescribing this medication to women of childbearing potential and to weigh the potential benefits against any unknown risks. It is recommended that healthcare providers discuss the implications of medication use during pregnancy with their patients, ensuring informed decision-making.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is essential.

Management procedures should include monitoring vital signs and providing supportive care as needed. In cases where the specific substance is known, appropriate antidotes or treatments should be administered as per established protocols.

It is vital for healthcare providers to remain vigilant and act swiftly to mitigate the potential risks associated with overdosage.

Nonclinical Toxicology

No information is available regarding teratogenic or non-teratogenic effects. Additionally, there is no data provided concerning nonclinical toxicology, animal pharmacology, or toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

When using this product, it is important to inform patients that skin irritation and dryness may be more likely to occur if they are using another topical acne medication concurrently. Therefore, if irritation develops, patients should be instructed to use only one topical acne medication at a time to minimize the risk of adverse effects.

Additionally, healthcare providers should emphasize the importance of avoiding contact with the eyes. Instruct patients that if contact occurs, they should rinse their eyes thoroughly with water to prevent irritation or injury.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product in a dry and cool environment to maintain its integrity and efficacy. Proper storage conditions are critical to ensure the product remains effective throughout its shelf life.

Additional Clinical Information

The medication is administered topically, with a recommended application of a thin layer to the entire affected area one to three times daily. Patients should begin with one application daily and may gradually increase to two or three times daily as needed or directed by a clinician. In cases of bothersome dryness or peeling, it is advised to reduce the frequency to once a day or every other day.

Clinicians should counsel patients that the product is for external use only and that skin irritation and dryness may be exacerbated by concurrent use of other topical acne medications. Patients should avoid contact with the eyes, rinsing thoroughly with water if contact occurs. Additionally, the medication should be kept out of reach of children, and immediate medical assistance should be sought if swallowed.

Drug Information (PDF)

This file contains official product information for Spot Stopper Acne Spot Treatment, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)